<DOC>
	<DOC>NCT01349114</DOC>
	<brief_summary>The study will evaluate the effects of the direct renin inhibitor, aliskiren, on flow-mediated dilation of the brachial artery and on central aortic pressure in diabetic patients with pre-hypertension or Stage 1 hypertension.</brief_summary>
	<brief_title>Effect of the Direct Renin Inhibitor Aliskiren on Endothelial Function and Arterial Stiffness in Diabetic Subjects</brief_title>
	<detailed_description>Patients are double-blind placebo-controlled randomized to either aliskiren or sugar pill/placebo. Effects on blood parameters and arteries are evaluated in both groups.</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Prehypertension</mesh_term>
	<criteria>Type 2 diabetes prehypertension or Stage 1 hypertension Type 1 diabetes Stage 2 hypertension CKD recent MI, revascularization, CVA or TIA</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>aliskiren</keyword>
	<keyword>endothelial function</keyword>
	<keyword>hypertension</keyword>
</DOC>